3rd RSC / SCI New Therapeutics for Global Health


3rd RSC / SCI New Therapeutics for Global Health


Monday 9th – Wednesday 11th September, 2024


Cranfield Management Development Centre, Cranfield University, Milton Keynes, UK

Important links and downloads

Twitter hashtag – #NTGH24
To download the venue guide, click here
To download the first announcement poster, click here
To submit an abstract, click here


Tuberculosis, malaria and diseases caused by a diverse range of pathogens, including flaviviruses (eg dengue, West Nile), kinetoplastids (causative agents of Chagas disease, leishmaniasis, etc) and gut pathogens (worms, bacteria, parasites), remain a cause of high mortality across the globe. Fortunately, an ever-improving understanding of the complex life-cycles of these disease-causing pathogens is presenting increasing opportunities for those seeking to tackle these global health problems.

This meeting will focus on medicinal chemistry approaches to developing new medicines for diseases affecting global health. Keynote talks from international experts from industry and academia, alongside perspectives detailing case histories in drug discovery, will highlight the latest developments in the field whilst also showcasing the opportunity for creativity and innovation

Call for abstracts:

Abstract submission is open, click here to submit.
The oral submission deadline is Thursday 29th February 2024.
The poster submission deadline is 26th April 2024.


Registration will be open soon.  Please keep checking back for updates!

Registration fees:

 Registration Rate
RSC/SCI Member*  £320.00
Non-member Standard  £400.00
RSC/SCI Student** member*   £175.00
Student** non-member £250.00
Member* LMIC*** Contact Hg3
Non-member LMIC*** Contact Hg3
Student** member* LMIC*** Contact Hg3
Student** non-member LMIC*** Contact Hg3










Venue and Travel

Detailed travel information can be found in this Venue Guide or the venue website here.

Want to become a member?

To join the RSC in order to qualify for discounted registration fees at all RSC, please follow this RSC link.

Exhibition/Sponsorship Opportunities

The Exhibitor Package (£1,500) comprises:

  • A six foot trestle table and chairs
  • Access to electricity and wi-fi
  • Logo inclusion in pdf of delegate handbook and rolling slides and conference website
  • Exhibitors promotional page in the pdf delegate handbook
  • One stand personnel with access to technical sessions
  • Attendance at the Tuesday evening social event – Conference Dinner

The Sponsorship Package (from £500) comprises:

  • your logo in the delegate handbook
  • your web-linked company name on the event web page
  • your logo in the rolling slides, shown during the breaks and verbal thanks from meeting chair

Confirmed Speakers

Pedro Alonso, Faculty of Medicine & Hospital Clinic University of Barcelona

Development of anti-malarial drug discovery in Ghana
Richard K Amewu, University of Ghana

Antimalarial Research & Drug Discovery – tackling the next frontiers
Jeremy Burrows, Medicines for Malaria Venture

New treatments for cryptosporidiosis with optimal properties for targeting gastrointestinal infection
Nicola Caldwell, University of Dundee

Discovering new TB agents for the future with novel modes of action
Laura Cleghorn, University of Dundee

Next Generation Oxazolidinone Antibiotics for the Treatment of Tuberculosis
Brendan Cowley, Merck (MSD)

Design of Potent and Orally Available Antimalarial PMX Inhibitors  via Molecular Property Optimization
Teresa De Haro, UCB Biopharma

The discovery of a novel series of compounds with single-dose efficacy against juvenile and adult Schistosoma species
Mark Gardner, Salvensis

New Antivirals: AI and Structure Based Open Science and direct-to-generic approaches
Ed Griffin, MedChemica Ltd

Long acting medicines for treatment and prevention of high burden pathogens in low- and middle-income countries
Andrew Owen, University of Liverpool

Identifying new therapeutic options to overcome malaria resistance
Laura M Sanz-Alonso, GSK

Progress and challenges in treating global health diseases
Peter Warner, Bill & Melinda Gates Foundation

Organising Committee
Giancarlo Biagini – Liverpool School of Tropical Medicine
Martin Lowe (SCI) Chair
Jayshree Mistry (SCI) – Independent Consultant
Andrew Stachulski – BMCS University of Liverpool
Mary Wheldon (BMCS) Treasurer

Secretariat Contact and Further Information
Hg3 Conferences Ltd
+44 (0)1423 529333